The purpose of this webinar is to evaluate and discuss the methodological approaches outlined in the guidance and highlight several key areas that may warrant further consideration when designing and planning for studies involving abuse potential. Guest speakers are industry leaders in the evaluation of preclinical and clinical abuse and dependence evaluation.